EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Comparison of the Thrombolytic Effects of Urokinase Delivered by Normothermic Machine Perfusion or Hypothermic Machine Perfusion in a Pair of Human Kidneys With Microthrombus

Shuangjin Yu, Guobin Wu, Yang Huang, Haiwei Chen, Tong Chen, Hehuan Ruan, Xiaoshun He, Guodong Chen, Jiang Qiu

Organ Medicine · 2024

DOI: 10.1002/orm2.13 ↗
AstrattDettalji biblijografiċi

Astratt

ABSTRACT Extensive glomerular thrombosis can be a reason for the non‐use of donor kidneys, which exacerbates donor shortage. Pre‐transplantation intervention with thrombolytic drugs delivered via hypothermic machine perfusion (HMP) can dissolve thrombi in kidneys with thrombosis. However, this method requires a long intervention time to fully eliminate all thrombi. This increases the period of ischemia and limits the improvement of the kidney. We compared the effect of short‐term thrombolysis by urokinase combined with normothermic machine perfusion (NMP) versus HMP in a pair of clinically discarded and pathologically confirmed thrombotic human donor kidneys. During perfusion with urokinase for 1 h, improvement of kidney appearance, perfusion flow, urine production, thrombus break‐down, and plasminogen consumption were all greater with NMP than with HMP. The renal glomerular thrombosis rate in the NMP‐treated kidney decreased from 13.3% (2 in 15) to 8.3% (1 in 12) after 30 min of urokinase administration, accompanied by decreased levels of plasminogen in the renal tubular cells (the positive area decreased from 13.1% to 7.5%). In contrast, both the renal glomerular thrombosis rate and plasminogen level were unchanged during HMP. Furthermore, D‐dimer in the NMP perfusate increased rapidly from 1.55 to 7.33 µg/mL, compared with from 0.33 µg/mL to 0.86 µg/mL in HMP perfusate. Our findings indicate that the effect of urokinase to facilitate rapid thrombolysis before transplantation is greater when administered by NMP than by HMP. NMP can, therefore, improve donor kidney quality more efficiently than HMP.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →